EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19

    NEXT STORY
    Skylight Health Appoints Andrew Elinesky as Chief Financial Officer
    PREV STORY
    Ascendis Pharma A/S Announces New “Outgrow GHD” Educational Resource to Support Rare Disease Day 2021
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cerner and Lumeris Will Launch Offering to Reduce Complexities for Health Systems Delivering Value-Based Care

    Collaboration will create an EHR-agnostic offering, Maestro Advantage(TM), designed to help providers who participate ...

    author_avatar
    NASDAQ Market News

    OncXerna Therapeutics Appoints Colleen Mockbee as Chief Development Officer and Senior Vice President of Regulatory Affairs

    author_avatar
    NASDAQ Market News

    Inovio will Independently Develop Hepatitis B Immunotherapy

    PLYMOUTH MEETING, Pa., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today ...

    author_avatar
    NASDAQ Market News